Impact of age and heterophilic interference on the basal serum tryptase, a risk indication for anaphylaxis, in 1,092 dermatology patients

Acta Dermato-Venereologica

Volumn 92, Issue 5, 2012, Pages 484-489

  Schliemann, Sibylle ^a   Seyfarth, Florian ^a   Hipler, Uta Christina ^a   Elsner, Peter ^a  

^a JENA UNIVERSITY HOSPITAL   (Germany)

Author keywords

Age related effects; Baseline serum tryptase; Heterophilic antibody; Heterophilic blocking tubes; Hymenoptera venom allergy; Mastocytosis

Indexed keywords

HETEROPHILE ANTIBODY; TRYPTASE;

ADOLESCENT; ADULT; AGED; ANAPHYLAXIS; ARTICLE; CHILD; ENZYME BLOOD LEVEL; FEMALE; GROUPS BY AGE AND SEX; HETEROPHILIC BLOCKING TUBE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK; SCHOOL CHILD; TUBE;

ADOLESCENT; ADULT; AGE FACTORS; AGING; ANAPHYLAXIS; ANIMALS; ANTIBODIES, HETEROPHILE; BEE VENOMS; BIOLOGICAL MARKERS; CHI-SQUARE DISTRIBUTION; CHILD; CHILD, PRESCHOOL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; HYMENOPTERA; INFANT; INFANT, NEWBORN; INSECT BITES AND STINGS; MALE; MASTOCYTOSIS; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; TRYPTASES; UP-REGULATION; YOUNG ADULT;

EID: 84859722094     PISSN: 00015555     EISSN: 16512057     Source Type: Journal    
DOI: 10.2340/00015555-1245     Document Type: Article

References (44)

1. Blum S, Gunzinger A, Muller UR, Helbling A. Influence of total and specific IgE, serum tryptase, and age on severity of allergic reactions to Hymenoptera stings. Allergy 2010; 66: 222-228.
2. Schwartz LB. Diagnostic value of tryptase in anaphylaxis and mastocytosis. Immunol Allergy Clin North Am 2006; 26: 451-463.
3. Caughey GH. Tryptase genetics and anaphylaxis. J Allergy Clin Immunol 2006; 117: 1411-1414.
4. Bilo BM, rueff F, Mosbech H, Bonifazi F, Oude-Elberink JN. Diagnosis of Hymenoptera venom allergy. Allergy 2005; 60: 1339-1349.
5. Yunginger JW, Nelson DR, Squillace DL, Jones RT, Holley KE, Hyma BA, et al. Laboratory investigation of deaths due to anaphylaxis. J Forensic Sci 1991; 36: 857-865.
6. Haeberli G, Bronnimann M, Hunziker T, Muller U. Elevated basal serum tryptase and hymenoptera venom allergy: relation to severity of sting reactions and to safety and ef-fcacy of venom immunotherapy. Clin Exp Allergy 2003; 33: 1216-1220.
7. Payne V, Kam PC. Mast cell tryptase: a review of its physiology and clinical signifcance. Anaesthesia 2004; 59: 695-703.
8. Ludolph-Hauser D, rueff F, Fries C, Schopf P, Przybilla B. Constitutively raised serum concentrations of mast-cell tryptase and severe anaphylactic reactions to hymenoptera stings. lancet 2001; 357: 361-362.
9. Rueff F, Przybilla B, Bilo MB, Muller U, Scheipl F, Aberer W, et al. Predictors of severe systemic anaphylactic reactions in patients with hymenoptera venom allergy: importance of baseline serum tryptase - a study of the European Academy of Allergology and Clinical Immunology Interest Group on Insect Venom Hypersensitivity. J Allergy Clin Immunol 2009; 124: 1047-1054.
10. Przybilla B, Müller U, Jarisch R, Rueff F. Erhöhte basale Serumtryptasekonzentration oder Mastozytose als risi-kofaktor der Hymenopterenallergie. Allergo J 2004; 13: 440-442.
11. Kleine-Tebbe J. Die spezifsche Immuntherapie (Hypo-sensibilisierung) bei IgE-vermittelten allergischen Erkran-kungen. Allergo J 2009; 18: 508-537.
12. Dybendal T, Guttormsen AB, Elsayed S, Askeland B, Harboe T, Florvaag E. Screening for mast cell tryptase and serum IgE antibodies in 18 patients with anaphylactic shock during general anaesthesia. Acta Anaesthesiol Scand 2003; 47: 1211-1218.
13. Brockow K, Jofer C, Behrendt H, ring J. Anaphylaxis in patients with mastocytosis: a study on history, clinical features and risk factors in 120 patients. Allergy 2008; 63: 226-232.
14. Schwartz LB, Min HK, ren S, Xia HZ, Hu J, Zhao W, et al. Tryptase precursors are preferentially and spontaneously released, whereas mature tryptase is retained by HMC-1 cells, Mono-Mac-6 cells, and human skin-derived mast cells. J Immunol 2003; 170: 5667-5673.
15. Valent P, Akin C, Escribano L, Fodinger M, Hartmann K, Brockow K, et al. Standards and standardization in mas-tocytosis: consensus statements on diagnostics, treatment recommendations and response criteria. Eur J Clin Invest 2007; 37: 435-453.
16. Rueff F, Placzek M, Przybilla B. Mastocytosis and hyme-noptera venom allergy. Curr Opin Allergy Clin Immunol 2006; 6: 284-288.
17. Fricker M, Helbling A, Schwartz L, Muller U. Hymenoptera sting anaphylaxis and urticaria pigmentosa: clinical fndings and results of venom immunotherapy in ten patients. J Allergy Clin Immunol 1997; 100: 11-15.
18. Oude Elberink JN, de Monchy JG, Kors JW, van Doormaal JJ, Dubois AE. Fatal anaphylaxis after a yellow jacket sting, despite venom immunotherapy, in two patients with masto-cytosis. J Allergy Clin Immunol 1997; 99: 153-154.
19. Ludolph-Hauser D, Schopf P, Rueff F, Przybilla B. Okkulte kutane Mastozytose. Hautarzt 2001; 52: 390-393.
20. de Gennes C, Kuntz D, de Vernejoul MC. Bone mastocyto-sis. A report of nine cases with a bone histomorphometric study. Clin Orthop relat res 1992; 279: 281-291.
21. Bredfeldt JE, O'laughlin JC, Durham JB, Blessing LD. Malabsorption and gastric hyperacidity in systemic masto-cytosis. results of cimetidine therapy. Am J Gastroenterol 1980; 74: 133-137.
22. Thomas D, Dragodanne C, Frank R, Prier A, Chomette G, Grosgogeat Y. Systemic mastocytosis with myo-pericardial localization and atrioventricular block. Arch Mal Coeur Vaiss 1981; 74: 215-221 (in French).
23. Sperr WR, Jordan JH, Baghestanian M, Kiener HP, Samo-rapoompichit P, Semper H, et al. Expression of mast cell tryptase by myeloblasts in a group of patients with acute myeloid leukemia. Blood 2001; 98: 2200-2209.
24. Kricka LJ. Human anti-animal antibody interferences in immunological assays. Clin Chem 1999; 45: 942-956.
25. Levinson SS, Miller JJ. Towards a better understanding of heterophile (and the like) antibody interference with modern immunoassays. Clin Chim Acta 2002; 325:1-15.
26. van Toorenenbergen AW, Hooijkaas H, Heerenbrink GK, Dufour-van den Goorbergh DM. Heterophilic antibody interference in a tryptase immunoassay. Clin Biochem 2008; 41: 331-334.
27. van Toorenenbergen AW, van Daele PL, Boonstra JG. False-elevated serum tryptase assay result caused by he-terophilic antibodies. J Allergy Clin Immunol 2005; 116: 1159-1160.
28. Moorman JE, rudd RA, Johnson CA, King M, Minor P, Bailey C, et al. National surveillance for asthma - United States, 1980-2004. MMWr Surveill Summ 2007; 56: 1-54.
29. Sargur R, Cowley D, Murng S, Wild G, Green K, Shrimpton A, et al. Raised tryptase without anaphylaxis or mastocyto-sis: heterophilic antibody interference in the serum tryptase assay. Clin Exp Immunol 2011; 163: 339-345.
30. Holm S. A simple sequentially rejective multiple test procedure. Scand J Stat 1979; 6: 65-70.
31. Valent P, Horny HP, Li CY, longley JB, Metcalfe DD, Parwaresch RM, et al. Mastocytosis (mast cell disease). World Health Organization classification of tumours: pathology and genetics. In: Jaffe ES, Harris Nl, Stein H, Vardiman JW, editors. Tumours of haematopoietic and lymphoid tissues. Geneva: WHO; 2001, p. 291-302.
32. Kucharewicz I, Bodzenta-lukaszyk A, Szymanski W, Mroczko B, Szmitkowski M. Basal serum tryptase level correlates with severity of hymenoptera sting and age. J Investig Allergol Clin Immunol 2007; 17: 65-69.
33. Guenova E, Volz T, Eichner M, Hoetzenecker W, Caroli U, Griesinger G, et al. Basal serum tryptase as risk assessment for severe Hymenoptera sting reactions in elderly. Allergy 2010; 65: 919-923.
34. Gonzalez-Quintela A, Vizcaino L, Gude F, Rey J, Meijide L, Fernandez-Merino C, et al. Factors infuencing serum total tryptase concentrations in a general adult population. Clin Chem lab Med 2010; 48: 701-706.
35. Sperr WR, Stehberger B, Wimazal F, Baghestanian M, Schwartz LB, Kundi M, et al. Serum tryptase measurements in patients with myelodysplastic syndromes. leuk lym-phoma 2002; 43: 1097-1105.
36. Dugas-Breit S, Schopf P, Dugas M, Schiff H, Rueff F, Przybilla B. Baseline serum levels of mast cell tryptase are raised in hemodialysis patients and associated with severity of pruritus. J Dtsch Dermatol Ges 2005; 3: 343-347.
37. Hidvegi B, Nagy E, Szabo T, Temesvari E, Marschalko M, Karpati S, et al. Correlation between T-cell and mast cell activity in patients with chronic urticaria. Int Arch Allergy Immunol 2003; 132: 177-182.
38. Fukuoka Y, Schwartz LB. Active monomers of human beta-tryptase have expanded substrate specificities. Int Immunopharmacol 2007; 7: 1900-1908.
39. Candore G, Di lorenzo G, Mansueto P, Melluso M, Frada G, Li Vecchi M, et al. Prevalence of organ-specific and non organ-specific autoantibodies in healthy centenarians. Mech Ageing Dev 1997; 94: 183-190.
40. Manoussakis MN, Tzioufas AG, Silis MP, Pange PJ, Goudevenos J, Moutsopoulos HM. High prevalence of anti-cardiolipin and other autoantibodies in a healthy elderly population. Clin Exp Immunol 1987; 69: 557-565.
41. Hurez V, Kaveri SV, Kazatchkine MD. Expression and control of the natural autoreactive IgG repertoire in normal human serum. Eur J Immunol 1993; 23: 783-789.
42. lacroix-Desmazes S, Mouthon L, Coutinho A, Kazatch-kine MD. Analysis of the natural human IgG antibody repertoire: life-long stability of reactivities towards self antigens contrasts with age-dependent diversifcation of reactivities against bacterial antigens. Eur J Immunol 1995; 25: 2598-2604.
43. Lacroix-Desmazes S, Mouthon L, Kaveri SV, Kazatch-kine MD, Weksler ME. Stability of natural self-reactive antibody repertoires during aging. J Clin Immunol 1999; 19: 26-34.
44. Min HK, Moxley G, Neale MC, Schwartz LB. Effect of sex and haplotype on plasma tryptase levels in healthy adults. J Allergy Clin Immunol 2004; 114: 48-51.